Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-045238
Filing Date
2024-05-20
Accepted
2024-05-20 16:47:20
Documents
86
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206528-10q_cambell.htm   iXBRL 10-Q 701473
2 CERTIFICATION ea020652801ex31-1_cambell.htm EX-31.1 9700
3 CERTIFICATION ea020652801ex32-1_cambell.htm EX-32.1 3180
4 GRAPHIC image_001.jpg GRAPHIC 20771
5 GRAPHIC image_002.jpg GRAPHIC 19468
6 GRAPHIC image_003.jpg GRAPHIC 55923
7 GRAPHIC image_004.jpg GRAPHIC 47294
8 GRAPHIC image_005.jpg GRAPHIC 34603
  Complete submission text file 0001213900-24-045238.txt   5433599

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE bimt-20240331.xsd EX-101.SCH 61046
10 XBRL CALCULATION FILE bimt-20240331_cal.xml EX-101.CAL 42376
11 XBRL DEFINITION FILE bimt-20240331_def.xml EX-101.DEF 235540
12 XBRL LABEL FILE bimt-20240331_lab.xml EX-101.LAB 405080
13 XBRL PRESENTATION FILE bimt-20240331_pre.xml EX-101.PRE 232645
90 EXTRACTED XBRL INSTANCE DOCUMENT ea0206528-10q_cambell_htm.xml XML 575873
Mailing Address UNIT NO. 5784 152 CHARTERED SQUARE BUILDING, 212/19 BANGKOK W1 10500
Business Address UNIT NO. 5784 152 CHARTERED SQUARE BUILDING, 212/19 BANGKOK W1 10500 7026050123
CAMBELL INTERNATIONAL HOLDING CORP. (Filer) CIK: 0001678848 (see all company filings)

EIN.: 981310024 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-214469 | Film No.: 24965304
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)